Calendar Inovio Pharmaceuticals, Inc.

Equities

INO

US45773H4092

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
13.88 USD +6.52% Intraday chart for Inovio Pharmaceuticals, Inc. +28.64% +126.80%

Chart calendar Inovio Pharmaceuticals, Inc.

139b85e3490bd3e11439cf6d150.OsLc2WDFtVNCVyVjgPPLbA1o1ByEqrv15JzZsb2IHlE.c7eS4QacjQcGBB0mwoeEDn4juHiy9cissaSS3tX-UWlyoIqeVvXtZRQEZA~60f957a8b1de48fb1e3aed12d2665140

Upcoming events on Inovio Pharmaceuticals, Inc.

2024-04-02 10:00 am The Novel Therapeutics Forum
2024-04-07 04:30 pm American Association for Cancer Research Meeting - Abstract No:1191
2024-04-07 04:30 pm American Association for Cancer Research Meeting - Abstract No:976
2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)

Past events on Inovio Pharmaceuticals, Inc.

2024-03-06 04:30 pm Q4 2023 Earnings Call
2024-03-06 04:05 pm Q4 2023 Earnings Release
2024-02-14 12:40 pm Oppenheimer Healthcare Life Sciences Conference - Fireside Chat
2024-01-24 Reverse Split: 1 of 12
2024-01-12 11:00 am Extraordinary Shareholders Meeting
2023-11-09 04:30 pm Q3 2023 Earnings Call
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-09-12 04:30 pm H.C. Wainwright Global Investment Conference
2023-08-09 04:30 pm Q2 2023 Earnings Call
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-06-09 08:00 am Jefferies Global Healthcare Conference - Fireside Chat
2023-05-17 04:05 pm RBC Global Healthcare Conference
2023-05-16 09:00 am Annual General Meeting
2023-05-10 04:30 pm Q1 2023 Earnings Call
2023-05-10 04:05 pm Q1 2023 Earnings Release
2023-05-05 09:00 am American Broncho-Esophagological Association Combined Otolaryngology Spring Meeting
2023-04-16 02:30 am European of Clinical Microbiology and Infectious Diseases Congress - Abstract No : MMK0202
2023-03-13 10:40 am Oppenheimer Healthcare Conference
2023-03-01 04:30 pm Q4 2022 Earnings Call
2023-03-01 04:05 pm Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,11
5,11
-19.55%
7,41
3,84
93.02%
1,77
1,46
21.45%
10,3
10,6
-2.75%
0,83
1,07
-22.05%

0,60

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-298
-258
-15.56%
-263
-245
-7.61%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-111
-104
-6.96%
-124
-131
5.51%
-301
-259
-16.14%
-268
-253
-5.71%
-144
-139
-3.2%

-110

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-121
-107
-13.32%
-163
-179
9.13%
-303
-259
-17.07%
-278
-263
-5.61%
-135
-137
1.22%

-102

Net income
Million USD
Released
Forecast
Spread
-119
-106
-12.49%
-166
-181
8.13%
-304
-261
-16.33%
-280
-264
-6.02%
-135
-137
1.55%

-99,4

EPS
USD
Released
Forecast
Spread
-14,5
-12,9
-12.48%
-12,8
-14,1
8.84%
-17,4
-15,2
-14.68%
-14,0
-13,3
-5.6%
-6,09
-5,11
-19.08%

-3,85

Announcement Date12/03/2001/03/2101/03/2201/03/2306/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,84
0,55
52.59%
0,20
0,66
-69.99%
0,78
0,52
50.65%
9,15
0,62
1368.96%
0,12
0,42
-70.6%
0,11
0,28
-58.2%
0,23
0,26
-13.92%
0,39
0,26
47.98%
0,10
0,34
-70.17%

0,15


0,15


0,15


0,15

EBITDA
Million USD
Released
Forecast
Spread
-104
-64,4
-62.28%



-103
-70,1
-47.05%
-34,7
-70,5
50.72%
-54,9
-37,3
-47.24%
























EBIT
Million USD
Released
Forecast
Spread
-106
-63,6
-65.93%
-71,7
-74,5
3.67%
-104
-67,0
-55.35%
-35,8
-70,1
49%
-55,9
-41,5
-34.92%
-44,0
-34,4
-27.66%
-37,0
-35,8
-3.61%
-35,6
-34,9
-1.82%
-27,4
-25,0
-9.5%

-27,6


-27,0


-27,8


-27,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-107
-63,1
-69.51%
-79,1
-74,7
-5.82%
-108
-67,3
-61.25%
-37,8
-70,4
46.36%
-54,5
-42,6
-27.9%
-40,6
-38,4
-5.85%
-35,5
-38,1
6.64%
-33,9
-34,3
1.19%
-25,0
-26,1
4.14%

-25,8


-25,0


-26,0


-25,4

Net income
Million USD
Released
Forecast
Spread
-107
-64,9
-64.9%
-79,1
-74,7
-5.82%
-108
-69,2
-56.88%
-37,8
-71,8
47.4%
-54,5
-41,7
-30.49%
-40,6
-36,7
-10.64%
-35,5
-38,1
6.64%
-33,9
-34,3
1.19%
-25,0
-26,1
4.14%

-24,3


-23,7


-24,2


-23,8

EPS
USD
Released
Forecast
Spread
-6,00
-3,83
-56.79%
-4,32
-4,12
-4.86%
-5,52
-3,74
-47.59%
-1,80
-3,55
49.27%
-2,64
-2,02
-30.95%
-1,92
-1,74
-10.34%
-1,56
-1,74
10.34%
-1,56
-1,52
-2.63%
-5,67
-1,24
-356.34%

-1,00


-0,96


-0,96


-0,93

Announcement Date01/03/2210/05/2209/08/2208/11/2201/03/2310/05/2309/08/2309/11/2306/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise